Cost-effectiveness analysis of human papillomavirus DNA testing and Pap smear for cervical cancer screening in a publicly financed health-care system

被引：0
作者：
I H-I Chow
C-H Tang
S-L You
C-H Liao
T-Y Chu
C-J Chen
C-A Chen
R-F Pwu
机构：
[1] School of Health Care Administration,Department of Obstetrics and Gynecology
[2] Taipei Medical University,Department of Obstetrics and Gynecology
[3] Gynecology Research Center,undefined
[4] Taipei Medical University Hospital,undefined
[5] Genomics Research Center,undefined
[6] Academia Sinica,undefined
[7] School of Public Health,undefined
[8] National Defense Medical Center,undefined
[9] Institute of Health Policy and Management,undefined
[10] National Taiwan University,undefined
[11] Center for Drug Evaluation,undefined
[12] Buddhist Tzu Chi General Hospital,undefined
[13] Tzu Chi University,undefined
[14] Center of Cervical Cancer Prevention,undefined
[15] Buddhist Tzu Chi General Hospital,undefined
[16] Tzu Chi University,undefined
[17] Graduate Institute of Epidemiology,undefined
[18] College of Public Health,undefined
[19] National Taiwan University,undefined
[20] College of Medicine,undefined
[21] National Taiwan University,undefined
来源：
British Journal of Cancer | 2010年 / 103卷
关键词：
HPV DNA testing; Pap smear; cost-effectiveness analysis; cervical cancer; screening;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1773 / 1782
页数：9
相关论文
共 253 条
[1]  
Agorastos T(2005)Self-sampling Int J STD AIDS 16 727-729
[2]  
Dinas K(2008) physician-sampling for human papillomavirus testing Aust N Z J Public Health 32 43-52
[3]  
Lloveras B(2008)The cost-effectiveness of cervical screening in Australia: what is the impact of screening at different intervals or over a different age range? Salud Publica Mex 50 276-285
[4]  
Font R(2006)Cost-effectiveness of conventional cytology and HPV DNA testing for cervical cancer screening in Colombia Vaccine 24 S78-S89
[5]  
Kornegay JR(2008)Chapter 9: clinical applications of HPV testing: a summary of meta-analyses Value Health 11 886-897
[6]  
Bontis J(2008)Optimal cost-effectiveness decisions: the role of the cost-effectiveness acceptability curve (CEAC), the cost-effectiveness acceptability frontier (CEAF), and the expected value of perfection information (EVPI) Int J Cancer 122 372-376
[7]  
De Sanjose S(2009)Cost-effectiveness of primary cytology and HPV DNA cervical screening Br J Cancer 101 174-177
[8]  
Anderson R(2009)Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences Value Health 13 169-179
[9]  
Haas M(2008)Cost-effectiveness of 21 alternative cervical cancer screening strategies Cancer Epidemiol Biomarkers Prev 17 2163-2168
[10]  
Shanahan M(2008)Self-sampling for human papillomavirus in a community setting: feasibility in hispanic women Vaccine 26 F16-F28
12345678910